dc.contributor.author | Balci, Huriye | |
dc.contributor.author | Seymen, Hakki Oktay | |
dc.contributor.author | Aytac, Erman | |
dc.contributor.author | Suzer, Oner | |
dc.contributor.author | Uzun, Hafize | |
dc.contributor.author | Dedeoglu, Burcak Deniz | |
dc.contributor.author | Seymen, Pinar | |
dc.date.accessioned | 2021-03-04T13:40:13Z | |
dc.date.available | 2021-03-04T13:40:13Z | |
dc.date.issued | 2008 | |
dc.identifier.citation | Dedeoglu B. D. , Aytac E., Suzer O., Balci H., Uzun H., Seymen P., Seymen H. O. , "Donor heart preservation with iloprost supplemented St. Thomas Hospital cardioplegic solution in isolated rat hearts", PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, cilt.78, sa.6, ss.415-421, 2008 | |
dc.identifier.issn | 0952-3278 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_7da2367b-dea0-4d78-abbb-325351b5478f | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/85827 | |
dc.identifier.uri | https://doi.org/10.1016/j.plefa.2008.05.004 | |
dc.description.abstract | This study was designed to assess the influence of St. Thomas Hospital cardioplegic solution (St. Th.) on heart preservation in rat hearts subjected to 6 h ischemia when supplemented with iloprost. In the control group (n = 8), nothing was added to St. Th., whereas 10 or 1000 nmol L(-1) iloprost was added in the second (n = 7) and third (n = 8) groups, respectively. Mechanical contraction parameters, cardiac tissue damage and oxidative stress markers were evaluated. The 10 nmol/L iloprost group peak systolic pressure (71.0+/-30.9 versus 41.0+/-9.4 mm Hg) and -dp/dt(max) (1103.8+/-94.3 versus 678.6+/-156.8 mm Hg s(-1)) were significantly higher than control group at 30 min of reperfusion (p<0.05). Iloprost supplemented groups had higher GSH and catalase levels of coronary perfusate at reperfusion, in comparison with initial values (p < 0.05). AST, CK, CK-MB values increased at 0 min of reperfusion and cTnI values at 45 min of reperfusion (p<0.05) in all groups with no difference between groups. According to our results, iloprost supplementation had mild but significant improvement in postischemic values in mechanical and oxidative stress parameters, resulting in better heart preservation. (C) 2008 Elsevier Ltd. All rights reserved. | |
dc.language.iso | eng | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Temel Tıp Bilimleri | |
dc.subject | Histoloji-Embriyoloji | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Endokrinoloji ve Metabolizma Hastalıkları | |
dc.subject | Yaşam Bilimleri | |
dc.subject | Moleküler Biyoloji ve Genetik | |
dc.subject | Sitogenetik | |
dc.subject | Temel Bilimler | |
dc.subject | Klinik Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Tıp | |
dc.subject | ENDOKRİNOLOJİ VE METABOLİZMA | |
dc.subject | HÜCRE BİYOLOJİSİ | |
dc.subject | Yaşam Bilimleri (LIFE) | |
dc.subject | Moleküler Biyoloji ve Genetik | |
dc.subject | BİYOKİMYA VE MOLEKÜLER BİYOLOJİ | |
dc.title | Donor heart preservation with iloprost supplemented St. Thomas Hospital cardioplegic solution in isolated rat hearts | |
dc.type | Makale | |
dc.relation.journal | PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.identifier.volume | 78 | |
dc.identifier.issue | 6 | |
dc.identifier.startpage | 415 | |
dc.identifier.endpage | 421 | |
dc.contributor.firstauthorID | 18772 | |